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Ahatrae-1. Ph~ph~il~ colon chro~to~aphy under double gradient ~nditions (phosphate and 
KCl) revcakd two forms of AMP deaminase in rat heart and brain and a single form in the liver and 
skeletal muscle. 
2. Kinetically all purifled AMP deaminases were classified into two categories: those, which elute from 
the column at lower KC1 and Pi concentrations, display low .S,,$ value are only moderately affected by 
MgATP, MgGTP and Pi; and those which elute at higher KCl and Pi concentrations, display high & 
values and are strongly regulated by allostezic effecters. 
3. Physiological significance of the occurrence of two kinetic forms of AMP deaminase. in some tissues 
is discussed. 
AMP deaminase (EC 3.5.4.6), which catalyzes hydro- 
lytic deamination of AMP, is an ubiquitous enzyme 
occurring in all eukariotic cells (Purzycka, 1962). The 
enzyme is regulated by a number of modulators. The 
most important are ATP (activator) and GTP and 
inorganic phosphate (inhibitors) (Setlow et al., 1966; 
Van den Berghe et al., 1977; Spychala et al., 1986). 
Its complex regulatory properties seem to be compat- 
ible with the control of adenine nucleotide break- 
down. This homeostatic function, vital for each living 
cell, has been most extensively studied with isolated 
cells systems (Chapman and Atkinson, 1973; Chap- 
man et al., 1976). These studies revealed that under 
conditions of intensified ATP utilization AMP deam- 
inase provides a mechanism which, together with 
adenylate kinase, stabilizes the relative concen- 
trations of adenylates at the cost of a net loss in the 
adenine nucleotide pool. In the heart, this function 
may be shared with Y-nucleotidase (Itoh et al., 1986; 
Skladanowski and Newby, 1990). 
However, the observation that the enzyme activity 
varies widely in animal tissues and the multiple 
molecular forms have been detected in some of them 
(Spychala et al., 1986; Ogasawara et al., 1972, 1978, 
1982), suggests a significant degree of diversity in 
the regulation of AMP degradation. In human and 
rat liver a single form of AMP deaminase has been 
described (Orals et al., 1978, 1982). On the 
other hand, in chicken liver, the occurrence of two 
forms of AMP deaminase seems to be associated with 
the intensive metabolism of purine nucleotides due to 
uricotelism (Spychala and Makarewicz, 1983; Spy- 
chala and Van den Berghe, 1987). Similarly, two 
kinetically distinct forms of AMP deaminase were 
purified from rat small intestine and a detailed kinetic 
studies have revealed that the form exhibiting a 
lower K, is less sensitive to activators and inhibitors. 
Compatible with our previous chromatographic and 
kinetic studies showing two forms of the enzyme in 
some tissues are genetic experiments showing the 
existence of two genes coding in for AMP deaminase 
in human and rat tissues (Sabina et af,, 1990). 
Therefore, it seemed worthwhile in investigate, 
in addition to the previous studies which focused 
mainly on chromatographic and immunological 
differences (Ogasawara et al., 1972, 1978, 1982), the 
tissue distribution of two previously described differ- 
ent AMP deaminases (Spychala and Malcarewicz, 
1983; Spychala et al., 1986) and compare their 
regulation by MgATPe2, MgGTPm2 and inorganic 
phosphate. 
Chemicals 
MATERIALS AND METHODS 
AMP (free acid) was purchased from Sigma Chemical 
Co., U.S.A. Phos&hoc&lose P-l 1 was sup&d by What- 
man. U.K. ATP (disodium sal0 and GTP ldisodium Sal0 
were from Boehringer Mannhe&, F.R.G. Sodium cocady: 
late and 2.mercaptocthanol were purchased from Loba 
Chem., Austria. All other reagents were of the highest purity 
available. 
Pwifcatiorz of AMP deaminase 
Male Wistar rats weighing 3w g were used through- 
out the study as a source of liver skeletal muscle, heart and 
brain. l%c animals were killed by decapitation and the 
tissues were ~~iately dissected, washed with ice-cold 
5 mM Tris-HCl pH 7.4 #n~~~ 1 mM rn~pt~~nol 
and i mh4 PMSF (buffer A), and then wei8hed. Ten 
grammes of each tissue were homogenized in 10 volumes of 
buffer A using a Waring-Blendor type homogenizer. The 
homogenate was then stirred for 10min at 4°C and cen- 
trifuged at 18,000 g for 30 min. 
Wet phosphoallulosc (20ml prepared as recommended 
by the manufacturer and extensively washed with 100 mM 
phosphate buffer and but&r A) was added to the super- 
natant fraction of the homogenate and the batch adsorption 
was carried out at 5°C for 30 min under gentle stirring. The 
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pho~h~i~~o~ slurry was then washed three times with 
0.25 M KC1 by repeated centrifugation and phtced in a 
column @%armacia K 161201. The column was then washed 
with 0.4-M KQ (adjusted to pH 7.0 was imidazole) and 
subsequently the AMP deaminase activity, was eluted using 
a double gradient of KC1 (0.4-0.7 M) and potassium phos- 
phate (O-O.1 M, pH 7.0, with KC1 in the mixing vessel and 
KC1 plus phosphate in the reservoir) at a flow of 20 ml/ hr. 
The fractions corresponding to each peak of activity were 
pooled, diluted S-fold with ice-cold 1 mM mercaptoethanol, 
adsorbed onto phosphoceflulose (5 ml of bed volume) for 
15 min and placed in the column. After washing with 0.4 M 
KCi, the e&ymes were eluted with 1 .O M KCi, pH 7.0 (in 
the case of form 11 or 1.2 M KCL DH 7.0 (in the case of form 
Enzyme assay 
AMP deaminase was assayed by means of ammonia 
determination (Chaney and Marbach, 1962). The reaction 
mixture contained 5OmM cacodylate buffer pH 7.2, 
150 mM KCl, 1 mM free MgCi,, 1 mM mercaptoethanol, 
1 m&ml bovine serum albumin and AMP concentrations as 
indicated. The incubation was carried out at 25°C for 
lO-30min and was terminated by the addition of phenol 
and hypochlorite reagents. The reaction was linear with 
protein and with time up to 60min. During the enzyme 
purification the enzyme activity was measured in 
K+/succinate buffer pH 6.5, 150mM KC1 and 1OmM 
AMP. 
For the evaluation of kinetic parameters nonlinear re- 
gression method was employed. Initial estimates for kinetic 
parameters (h and S,,) were computed from the data 
(0. i-O.9 of V_) using linear regression of the transformed 
Hill equation pog(r/Y - V) vs logs]. The experimental 
value of V_ was used for calculations at the initial stage. 
The final fit of experimental data to the kinetic function was 
performed using iterative, nonlinear least-squares data 
fitting. An algorithm developed by Marquardt (Marquardt, 
1963) was employed for this purpose. To facilitate the 
calculations an overall computer program was written in 
BASIC for the IBM PC (Marszalek ef al., 1,989). To obtain 
an equal distribution of experimental points (not less than 
12, ranging from 0.1-24 mM of substrate concentrations), 
preliminary experiments were performed under each con- 
dition. 
Protein assay 
Portein concentration was determined by the method of 
Bradford (Bradford, 1976) with bovine serum albumin as 
the reference. 
RESULTS 
The redesigned chromatographic procedure with 
double phosphate/KC1 gradient allowed reproducible 
and selective separation of two kinetic forms of AMP 
deaminase from chicken liver (Spychala and 
Makarewicz, 1983) and rat small intestine (Spychala 
ef al., 1986) and proved useful for the purpose of the 
present study. Therefore, this technique was used for 
the screening of rat tissues for the occurrence of 
multiple forms of this enzyme. A two-step procedure 
was employed. First, phosphocelhrlose column chro- 
matography in a double gradient mode was used to 
separate two forms of AMP deaminase and second, 
phosphocellulose column chromatography in a step 
elution mode was used to.further purify the enzyme, 
concentrate it and separate it from inorganic phos- 
phate. The 0.4 M KC1 wash during the first step did 
not elute any enzyme activity (Fig. 1). Subsequent 
elution with a double phosphate/KC1 gradient re- 
vealed two forms of AMP deaminase in rat heart and 
brain and single form in rat liver and skeletal muscle. 
They were classified as form I or II according to the 
e&ion sequence. Additional minor peaks of AMP 
deaminase activity were also observed with brain and 
heart extracts. The double phosphocellulose column 
chromatography procedure yielded highly purified 
enzyme preparations with specific activities of 9.8,2.5 
and 177.9~mol/min/mg for form I from the brain, 
heart and skeletal muscle and 20.0, 17.0 and 
11.9 fimol/min/mg for form II from the liver, brain 
and heart respectively. Enzyme preparations were 
essentially free of adenylate kinase, Y-nucleotidase, 
nonspecific phosphatase and adenosine deaminase 
activities. 
Kinetic properties of the obtained enzyme prep- 
arations were studied at pH 7.2 in the presence of 
various combinations of effecters including: ATP, 
inorganic phosphate and GTP: all at 1 mM MgCl, in 
excess of nucleoside triphosphates. Preliminary ex- 
periments showed no effect of magnesium ions on 
AMP deaminase preparations tested. The results 
shown in Table 1 indicate that all the enzymes tested 
fall into two categories. The first category includes 
forms which elute at a lower Pi and KC1 concen- 
trations from the phosphocellulose column, have 
substrate half-saturation values of controls in the 
range of 0.2 to 0.7 mM and are activated by MgATP 
only moderately (form I), and the second includes 
forms which elute at higher KC1 and phosphate 
concentrations, have & values in the range of 
3.2-5.7 mM and are strongly activated by MgATP 
(form II). In all cases, MgATP at 1 mM concen- 
tration activated purified AMP deaminases and inor- 
ganic phosphate and MgGTP inhibited them. 
However, in the presence of MgATP alone, the & 
values of all AMP deaminases were almost identical. 
The combined effect of modulators brought about 
enzyme activation when compared with controls in 
the case of all enzymes tested except for skeletal 
muscle AMP deaminase (Table 1). The maximal 
velocity values changed no more than 25% of control 
(data not shown). 
MgATP caused a shift in the kinetics from sig 
moidal to hyperbolic (Table 1). On the other hand, 
MgGTP and inorganic phosphate increased the sig 
moidicity in all enzymes tested. In addition, MgATP 
efficiently counteracted the effect of inhibitors on the 
Hill coefficient, except for AMP deaminase I from 
heart and skeletal muscle. 
DEXUSSION 
Multiple molecular forms of AMP deaminase 
have already been reported in rat and human 
tissues (Ggasawara et al., 1972, 1978, 1982). On 
the basis of immunological and chromatographic 
properties three Parental isoforms were proposed 
for rat: A (muscle), B (liver) and C (heart). Four 
isoforms have been proposed for humans: Bl 
and E2 (erythrocytes), M (muscle), and L (liver). 
It was postulated that other tissues possessed 
various combinations of these isozymes. However, 
the kinetic properties of some of the isozymes 
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Fig. 1. Phosphocellulose column elution profiles of AMP deaminase from rat liver, brain, heart and 
skeletal muscle. 
were only briefly presented and no conclusion could 
be drawn as far as their function is concerned 
(Ogasawara et al., 1978, 1982). 
In contrast to previous reports, which showed five 
peaks in rat brain (Ogasawara et al., 1972) and a 
single peak of AMP deaminase in rat heart 
(Ogasawara et al., 1978), we were able to observe two 
major activity peaks in both rat brain and heart. This 
apparent discrepancy could be explained on the basis 
of the different chromatographic techniques em- 
ployed. The interaction of AMP deaminase with the 
phosphocellulose resin occurs through the phosphate 
moiety and is most probably an affinity type (Spy- 
chala, 1987). Therefore, inorganic phosphate might 
be more selective in eluting AMP deaminase forms 
from phosph~llulo~ than KC1 or NaCl alone. The 
less probable explanation for the reduced number of 
peaks in rat brain may be related to the addition of 
PMSF, an inhibitor of serine proteases, since our 
preliminary studies without the inhibitor were almost 
identical to these presented here. Our two molecular 
forms of AMP deaminase may be classified as a 
low-K,,, (form I) and high-& (form II). 
Our studies are in agreement with the presence of 
two genes coding for AMP deaminase in rat and 
EC 23/W-K 
human tissues (Sabina et al., 1990). RNase protection 
analysis revealed that the amp’ gene is expressed at 
high level in skeletal muscle and heart and that the 
amp’ gene is expressed at low level in skeletal muscle 
but at high level in liver, brain and heart (Morisaki 
et al., 1990). The only unexplained discrepancy is the 
presence of AMP deaminase I in rat brain which was 
reported to express low level of amp’ gene. However, 
the presence of an additional transcript from the 
amp” gene cannot be ruled out. 
The kinetic properties of enzymes purified in essen- 
tially the same way were studied under conditions 
which approximate those found in viva. Although the 
predominant forms of ATP and GTP in the cell are 
MgATP-* and MgGTP-‘, ma~esium ions were 
rarely included in the incubation mixture in other 
studies. Studies with platelet and rat small intestine 
AMP deaminases have shown that magnesium ions 
strongly potentiate the allosteric effects exerted by 
ATP and GTP (Ashby and Holmsen, 1983; Spychala 
et al., 1986). 
The major kinetic difference between forms I and 
II relates to S,, values in the absence of effecters and 
to the degree of activation by MgATP. Form II has 
a 6-28-fold higher substrate half saturation constant 
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Table 1. Kinetic properties of two forms of AMP deaminase from 
rat liver, brain, heart and skeletal mlisde 
EVme AMP deaminase I AMP deaminase II 
and 
condition So,5 (mM) h .%, (mW h 
Liver 
Control - - 5.7 * 0.4 2.5 * 0.2 
1 mM ATP - - 0.3 f 0.1 1.0*0.1 
4mM P, - - 7.2 k 0.5 2.8 + 0.3 
0.2mM GTP - - 8.3 f 0.5 3.5 f 0.4 
ATP, GTP, Pi - - 1.0*0.2 1.2 + 0.1 
Brain 
Control 0.6+0.1 1.0 f 0.1 4.2 + 0.2 2.3 f 0.2 
1 mM ATP 0.2kO.02 0.8kO.2 0.3kO.2 1.350.3 
4mM Pi 0.9 * 0.1 1.9 + 0.2 6.3 f 0.2 2.9 f 0.3 
0.2 mM GTP 0.9kO.1 2.1kO.2 7.3kO.2 2.8kO.l 
ATP, GTP, P, 0.2Ito.02 1.0*0.1 1.2 * 0.1 1.1 kO.1 
Heart 
Control 0.2 +0.1 1.4kO.l 3.2 k 0.1 2.4 k 0.2 
1 mM ATP 0.1 * 0.01 1.0 * 0.3 0.1 +0.02 1.0 f 0.2 
4mM Pi 0.5 f 0.1 1.4kO.2 5.6+0.1 2.7 f 0.2 
0.2 mM GTP 0.6+0.1 2.4kO.l 6.250.1 3.8f0.2 
ATP, GTP, P, 0.2 f 0.03 2.2 f 0.6 0.7 f 0.1 1.2 f 0.3 
Muscle 
Control 0.7 * 0.1 1.9kO.l - - 
1 mM ATP 0.4+0.1 1.1+0.1 - - 
4mM P, 0.7 f 0.1 1.9*0.1 - - 
0.2 mM GTP 1.1 +0.1 2.6 * 0.2 - - 
ATP, GTP, Pi 0.9*0.1 2.6 kO.2 - - 
Assays were performed as described in Materials and Methods. Data 
are means, +S.D. from three experiments. S,$ is defined as a 
substrate concentration at half maximal velocity and was calcu- 
lated as described in Materials and Methods. h Represents Hill 
coefficient. 
and is also more activated by MgATP. MgATP 
lowers substrate affinity of form II from 13 to 32 
times, whereas the same parameter of form I is 
lowered by only a factor of 3. Interestingly, both 
AMP deaminase I and II are kinetically alike in the 
presence of MgATP. In general, form I is less suscep- 
tible to the regulation by MgATP, MgGTP and 
inorganic phosphate, whereas the activity of form II 
is significantly dependent on the presence of effecters, 
especially inhibitors. Although 4 mM Pi and 0.2 mM 
MgGTP alone affect the S,,, value of form I signifi- 
cantly, the fully activated enzyme (in the presence of 
MgATP) is not dramatically affected by these inhibi- 
tors. In contrast, AMP deaminase II from all sources 
and under these condition increase their & value 3-7 
times, from fully activated (MgATP only) to that in 
the presence of all effecters. Therefore, under pre- 
sumably physiological conditions, AMP deaminase I 
would be much more active. Surprisingly, AMP 
deaminase from skeletal muscle does not confirm 
entirely to the properties described for form I from 
heart and brain and seems to share some properties 
with form II as well. 
The significance of the coexistence of forms I and 
II in several tissues is unclear. It is possible that the 
presence of a low-K,,, form (either as an additional 
form in brain and heart of predominant form in 
skeletal muscle) may be associated with generally 
more intensive purine nucleotide metabolism; in 
chickens due to uricotelism, in hepatomas and small 
intestine epithelium due to the rapid growth, and in 
brain, skeletal muscle and heart due to intensive 
energy metabolism. Paradoxically, the comparison of 
rates of AMP deamination in isolated rat and chicken 
hepatocytes show that despite the presence of the 
form with low-K,,, and less strictly controlled by 
effecters and therefore more active under physiologi- 
cal conditions in the chicken, the catabolism of AMP 
is much slower (Van den Bergbe et al., 1980; Spychala 
and Van den Berghe, 1987). Thus, it is speculated that 
the appearance of the additional form of AMP 
deaminase in rat hepatoma (Jackson et al., 1977) or 
the regulation of the balance between form I and II 
in chicken liver on high protein feeding (Spychala and 
Marszalek, 1986) might not reflect the actual rate of 
AMP deamination but rather reflect the presence of 
an adaptive mechanism which regulates the ratio 
between the two forms of AMP deaminase. Whether 
it is the regulation of expression of amp’ and amp* 
genes or involves the existence of other cellular 
factors, remains to be established. 
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